Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial
Dong Ming Xu,Rob J. van Klaveren,Geertruida H. de Bock,Anne Leusveld,Yingru Zhao,Ying Wang,Rozemarijn Vliegenthart,Harry J. de Koning,Ernst T. Scholten,Johny Verschakelen,Mathias Prokop,Matthijs Oudkerk
DOI: https://doi.org/10.1016/j.ejrad.2007.08.027
IF: 4.531
2008-01-01
European Journal of Radiology
Abstract:Material and methods This study was institutional review board approved. For this study 405 participants of the NELSON lung cancer screening trial with 469 indeterminate or potentially malignant solid pulmonary nodules (>50 mm 3 ) were selected. The nodules were classified based on size, shape (round, polygonal, irregular) and margin (smooth, lobulated, spiculated). Mean nodule density and nodule volume were automatically generated by software. Analyses were performed by univariate and multivariate logistic regression. Results were presented as likelihood ratios (LR) with 95% confidence intervals (CI). Receiver operating characteristic analysis was performed for mean density as predictor for lung cancer. Results Of the 469 nodules, 387 (83%) were between 50 and 500 mm 3 , 82 (17%) >500 mm 3 , 59 (13%) malignant, 410 (87%) benign. The median size of the nodules was 103 mm 3 (range 50–5486 mm 3 ). In multivariate analysis lobulated nodules had LR of 11 compared to smooth; spiculated nodules a LR of 7 compared to smooth; irregular nodules a LR of 6 compared to round and polygonal; volume a LR of 3. The mean nodule CT density did not predict the presence of lung cancer (AUC 0.37, 95% CI 0.32–0.43). Conclusion In solid non-calcified nodules larger than 50 mm 3 , size and to a lesser extent a lobulated or spiculated margin and irregular shape increased the likelihood that a nodule was malignant. Nodule density had no discriminative power. Keywords Pulmonary nodules Margin Shape Density Multi-detector CT Lung cancer Screening 1 Introduction Lung cancer is today the most frequent cause of cancer deaths in the world [1] . In the United States, it was estimated that 171,600 people were diagnosed with this disease in 1999 (14.0% of the total number of cancer diagnosed), and about 158,900 people had died of this disease (28.2% of the total cancer death) [2] . More than two-thirds of these patients are diagnosed with locally advanced or metastatic disease, and their poor prognosis is due to late diagnosis and lack of effective treatment of metastatic disease. Less than 15% of the patients are surviving 5 years, and in several European countries the 5-year survival is far less [3] . Despite the optimal use of therapeutic resources, overall improvement in survival during the last decades has only been modest and major reductions in lung cancer mortality can only come from primary prevention, early detection and truly innovative treatments. Multi-detector low-dose spiral computer tomography (MDCT) is a relatively new technology that offers great potential as a screening tool because it is fast, potentially very accurate and relatively non-invasive. Therefore, the technology can be used for high throughput population screening purposes. Since the first publications of the use of the spiral CT in the early diagnosis of lung cancer, and especially the report from the Early Lung Cancer Action Program (ELCAP) in 1999 [4] , the interest in lung cancer screening by low-dose spiral CT has increased tremendously. In several screening studies it has been demonstrated that 55–80% of lung cancers detected by spiral CT screening are at a very early stage [5–8] . With the increasing use of the MDCT technology for lung cancer screening and the use of thinner slices, the number of screen detected nodules has increased substantially, which poses clinicians often for diagnostic dilemmas. The Fleischner Society [9] has recently issued recommendations for periodic follow-up scanning for this type of nodules, depending on their initial size. According to this recommendation, a nodule is benign if no growth has been observed after 24 months. Once growth has been demonstrated the likelihood of malignancy increases, but also benign lesions may grow [10] . If it were possible to identify subgroups of small pulmonary nodules less likely to be malignant, the follow-up rate for this type of lesions could be reduced. MDCT technology has not only led to an increased detection rate of pulmonary nodules, but at the same time improvements in spatial resolution and scanning time have given us the possibility to better analyse the internal and external characteristics of the nodules detected. Although many of these characteristics are already known for solitary pulmonary nodules (SPN) which are usually larger than 1 cm [11] , their applicability in the discrimination between benign and malignant in sub-centimeter solid screen detected pulmonary nodules is yet unknown. Purpose of this study is to evaluate prospectively the value of size, shape, margin and mean density in the discrimination between benign and malignant solid nodules detected at baseline screening of the Dutch-Belgian randomised lung cancer screening trial (NELSON). 2 Materials and methods 2.1 Participants The participants of the NELSON study underwent baseline screening for lung cancer by low-dose multi-detector CT. They were between 50 and 75 years of age and were recruited via population registries through mail. They had to be current or former smokers with a smoking history of >15 cigarettes/day for >25 years or >10 cigarettes/day for >30 years. Ineligible were those applicants who already underwent a pneumonectomy and those with a history of breast cancer, melanoma or hypernephroma. People with a history of other cancers were only eligible if curatively treated at least 5 years ago without signs of recurrence at the time of inclusion. The NELSON study was approved by the Medical Ethical Committees of all institutions and all subjects provided written informed consent. From April 2004 until July 2006, 7310 participants underwent baseline screening. For this particular study a subgroup of 405 participants with 387 indeterminate solid pulmonary nodules between 50 and 500 mm 3 (≤0 mm in diameter) and 82 screen-positive solid pulmonary nodules with a volume > 500 mm 3 (>10 mm in diameter) have been selected. The nodules had to be located purely intra-parenchymal without pleural-, fissure-attachment or juxtavascular location. For all these nodules either a 1-year follow-up or histological proof of benignancy or malignancy was available. 2.2 Data acquisition At all four screening sites 16-detector MDCT scanners were used (Mx8000 IDT or Brilliance 16P, Philips Medical Systems, Cleveland, OH, USA, or Sensation-16, Siemens Medical Solutions, Forchheim, Germany). Scanning of the entire chest was performed in caudo-cranial direction. Scan data were obtained in spiral mode, with 16 mm× 0.75 mm collimation and pitch 1.5. No contrast was used. Low-dose settings were applied. Depending on the body weight (<50, 50–80 and >80 kg), the kVp settings were 80–90, 120 and 140 kVp, respectively, to achieve a Computed Tomography Dose Index Volume (CTDIvol) of approximately 0.8, 1.6 and 3.2 mGy, respectively. The mAs settings were adjusted accordingly dependent on the machine used. To minimize breathing artefacts, scans were performed at suspended maximal inspiration after appropriate instruction of the subjects. Data were reconstructed at 1.0 mm slice thickness, with 0.7 mm reconstruction increment. 2.3 Image analysis All CT images were read twice independently. First readings were done by a radiologist with an experience in reading thoracic CT scans varying from 1 year to more than 20 years. Second readings were done by radiologists with 6 years of experience. In case of a discrepancy between the first and second reader, a third radiologist with more than 15 years of experience with lung CT made the final decision. The Syngo Lungcare © (Leonardo © workstation, Somaris/5 VB 10A Siemens Medical Solutions, Erlangen, Germany) software package designed to aid the radiologist in the diagnosis of pulmonary nodules was used in addition to visual readings. Baseline and follow-up images were reviewed and displayed simultaneously on one workstation. All images were interpreted both at lung window and mediastinal settings. 2.4 Nodule features The non-calcified solid nodules detected at baseline screening were classified into four different categories based on size and benign characteristics as described earlier [12] . Indeterminate nodules (Category III) were defined as nodules with volumes between 50 and 500 mm 3 , and screen-positive nodules (Category IV) as nodules larger than 500 mm 3 . In this study, all solid nodules were further classified based on shape (round/oval, polygonal or irregular) [13] , margin (smooth, lobulated or spiculated/irregular) [14] , and mean CT density in Hounsfield units (HU) (≤0, 0–100 or >100 HU). A nodule was polygonal when the entire lesion surface was surrounded by concave margins only [15] . Spiculation was defined as the presence of thicker strands extending from the nodule margin into the lung parenchyma without reaching the pleural surface [16] . Lobulation was defined as an abrupt bulging of the lesion contour [17] . Mean CT density of the nodule was calculated automatically by the Lungcare © software instead of specifying a region of interest. Volumes were calculated by three-dimensional (3D) volumetric computer software (Lungcare © software). In case of inappropriate segmentation, the radiologist was able to enter manual measurements as well, which then overruled the automatically generated volume calculations as described earlier [12] . Because cancer risk was absent at 1 year of follow-up in indeterminate solid nodules attached to either a vessel, the pleura or a fissure [18] , only purely intra-parenchymal indeterminate solid nodules and screen positive nodules have been included in this study. Nodules were classified as benign or malignant based on histological examinations of trans-thoracic needle biopsies or examination of surgical specimens. Nodules were also classified as benign if the volume doubling time (VDT) was >600 days or if the volume decreased at 1 year of follow-up. 2.5 Statistical analysis The Chi-square test for independence was used for comparisons of the presence of lung cancer among nodules within different categories of size, shape, margin or density. Univariate and multivariate logistic regression analyses were used to investigate the effect of the different nodule characteristics on the presence of lung cancer. Results are presented as likelihood ratios (LR) with 95% confidence intervals. Because mean nodule density and size were not normally distributed, a logarithmic transformation was performed before statistical analysis. Correlation analysis between density and nodule volume for lung cancer positive and negative cases was performed by Pearson's test. Receiver operating characteristic (ROC) analysis was performed for density as a predictor for the presence of lung cancer. p values < 0.05 were considered statistically significant. All values are expressed as means ± standard deviation (S.D.) and all analyses have been performed in SPSS version 14.0. 3 Results Between April 2004 and July 2006, in 405 participants 469 solid purely intra-parenchymal nodules of Category III and IV were detected which met the inclusion criteria. The mean age of the participants was 62 years (±5 years), 93% were males, 7% females. Of these 469 nodules, 387 (82%) were Category III and 82 (18%) Category IV, 59 (13%) malignant and 410 (87%) benign. The median size of the nodules was 103 mm 3 (range 50–5486 mm 3 ; median diameter 4.7 mm). The median CT density for benign nodules was 39 HU (range, −195 to 192 HU), and 11 HU (range, −128 to 7 HU) for malignant nodules ( p = 0.002). In Table 1 the distribution of the nodule characteristics is presented. For all variables except for nodule density, there was correlation with lung cancer ( p = 0.000), which was confirmed in univariate analysis ( Table 2 ). Lobulated, spiculated, irregular and Category IV nodules had an increased LR for lung cancer compared to smooth, round or polygonal and Category III nodules, respectively. The 95% CI intervals were very large, however, except for tumor volume. In multivariate analysis only tumor volume remained highly significant with a small 95% CI, while margin and shape just reached statistical significance, again with very wide 95% CI's ( Table 3 ). The ROC curve ( Fig. 1 ) illustrates that mean nodule CT density could not be used as a predictor for lung cancer (AUC 0.37, 95% CI 0.32–0.43). For lung cancer positive cases, the correlation coefficient between tumor volume and mean density was −0.05 ( p = ns), and for lung cancer negative cases 0.06 ( p = ns) ( Fig. 2 A and B ). Of the 469 solid nodules, 72 had a round contour, smooth margin and negative CT density (<0 HU). None of them became malignant at 1 year of follow-up. 4 Discussion The differentiation of benign form malignant pulmonary nodules detected within the context of a lung cancer screening programme is of great importance in order to reduce costs, anxiety and unnecessary additional investigations. It is therefore a great challenge to the specialist because the nodule remains frequently indeterminate at the end of the diagnostic process and surgical resection is often needed before a definitive diagnosis can be made. In a previous study, Xu et al. have demonstrated that in solid indeterminate nodules between 50 and 500 mm 3 lung cancer risk is absent at 1 year of follow-up in nodules attached to either a vessel, the pleura or a fissure while all lung cancer cases originated from purely intra-parenchymal nodules without attachment to these structures [18] . In the current study we investigated prospectively whether size, margin, shape and CT density could help in the discrimination between benign and malignant nodules. Although univariate analysis showed that lobulated, spiculated, irregular and Category IV nodules had an increased likelihood for lung cancer compared to smooth, round or polygonal and Category III nodules, respectively, the 95% CI intervals were very large, except for tumor volume. In multivariate analysis only tumor volume (size) remained highly significantly associated with the presence of lung cancer with small 95% CI's, while margin and shape just reached statistical significance, again with wide 95% CI's. Furthermore, we demonstrated that nodule density could not be used as a predictor, neither for lung cancer negative nor for lung cancer positive cases, although the density of malignant nodules appeared to be significant lower than that of benign nodules. The correlation between size and cancer risk found in our study has also been reported by other investigators [6,19–21] . The chance of being malignant is 0.9% for nodules between 4 and 7 mm, 18% for nodules 8–20 mm and 50% for those larger than 20 mm, while cancer risk is <0.2% for nodules less than 3 mm in diameter [9] . However, other features in addition to size can be helpful in the discrimination between benign and malignant pulmonary nodules [11,22] . The higher LR of cancer in nodules with a spiculated margin compared to round or polygonal nodules in our study is consistent with the results of previous studies in SPN's [22–24] , in which a spiculated contour occurs significantly more often in malignant SPNs. However, 95% CI intervals were wide, also limiting its use for SPN's in clinical practice. In pathological studies a spiculated contour was found to be due to thickened interlobular septa, fibrosis caused by obstruction of pulmonary vessels or lymphatic channels filled with tumor cells or extension to the pleura with pleural infiltration [23,24] . Nevertheless, also in benign SPN such as in inflammatory pseudotumors or tuberculomas spiculated edges may be found due to a desmoplastic response. With regard to the shape of benign and malignant SPN there is no agreement in the literature. Seemann reported that both benign and malignant SPN's could exhibit smooth edges [11,23] , while others found round or polygonal margins more often in benign lesions [16,22,25] . The pathologic substrate for lobulation in malignant lesions is the presence of nodular excrescences of the tumor at its advancing edge or tumor growth in islands at the periphery of the nodule, indicating that the nodule has uneven growth rates [10,24] . In our study of solid non-calcified pulmonary nodules, we found that the cancer cases had a significant lower mean density compared to benign nodules ( p < 0.05) most likely due to a lepidic growth pattern, the inclusion of air or an air bronchogram or regressive changes such as necrosis or hemorrhage within the tumor. This was consistent with the results of studies performed in usually larger SPN's [11,23,26,27] . Despite these findings, we do not recommend the use of nodule density in the differentiation between malignant and benign nodules because of the large overlap and the wide range of densities observed among the malignant nodules. In multivariate analysis nodule density was also not significant. Other investigators [11,23] also concluded that benign and malignant SNP's showed large variability in nodule density, particularly in the malignant group, with large overlap, and that size, shape and margin had only limited value in the identification of malignant from benign pulmonary nodules. Siegelman et al. suggested that a representative density value above 164 HU could be used to separate benign from malignant lesions, primarily because of diffuse calcifications in benign nodules [28] . However, this conclusion was not supported by the study by Seemann et al. [11] , who demonstrated that both benign and malignant solitary pulmonary nodules showed large range in lesion densities, particularly in the malignant group, with large overlap. Our results in small screen detected nodules are more or less consistent with the conclusions for larger SPN's, showing that size, shape and margin had only limited value in the identification of malignant from benign pulmonary nodules [23–25] . In the literature, there are several nodule classifications in use based on the external and internal features of the nodules, such as ragged, densely spiculated, somewhat irregular with slight spiculation or irregular with spiculation, but so far no standard classification is being used. According to our experience, some of these classifications are too complex and subjective for research purposes. For example, it is difficult to differentiate ragged nodule from lobulated and the same holds true for slightly and densely spiculated or coarse spiculation. This was also concluded by Li et al. who found large variability in the classification of the CT features by three different radiologists, especially for the margins of the nodule [25] . In order to minimize the inter-observer variability, we used a more simplified nodule classification as described in the method section. Future studies should focus on the further development of computer aided diagnosis (CAD) algorithms for small screen detected pulmonary nodules [29] . In our study, none of the round spherical nodules with a smooth margin and negative CT density became malignant at 1 year of follow-up, but the numbers are yet too small to draw final conclusions. Also changes in nodule shape and density over time might be associated with malignancy, and need further investigation. In conclusion, in solid non-calcified nodules larger than 50 mm 3 , size and to a lesser extent lobulated or spiculated margin and irregular shape increased the likelihood that the nodule was malignant. Nodule density had no discriminative power. Conflict of interest Not reported. Acknowledgements We would like to thank Peter Paul Taverne, Professor. Dr. Kris Nackaerts, René Vernhout, Estelle J.K. Noach, Wim Tukker, Peter van Ooijen and Fenneke van de Wiel for their efforts concerning data collection and management, providing us the population data from the central NELSON databases, English editing of the manuscript, data archiving and transferring. References [1] A. Pasic P.E. Postmus T.G. Sutedja What is early lung cancer? A review of the literature Lung Cancer 45 3 2004 267 277 [2] S.H. Landis T. Murray S. Bolden P.A. Wingo Cancer statistics, 1999 CA Cancer J Clin 49 1 1999 8 31 [3] R.J. van Klaveren J.D.F. Habbema J.H. Pedersen H.J. de Koning M. Oudkerk H.C. Hoogsteden Lung cancer screening by low-dose spiral computed tomography Eur Respir J 18 5 2001 857 866 [4] C.I. Henschke D.I. McCauley D.F. Yankelevitz Early Lung Cancer Action Project: overall design and findings from baseline screening Lancet 354 9173 1999 99 105 [5] S. Diederich D. Wormanns M. Semik Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers Radiology 222 3 2002 773 781 [6] J.K. Gohagan P.M. Marcus R.M. Fagerstrom Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer Lung Cancer 47 1 2005 9 15 [7] J.L. Mulshine D.C. Sullivan Clinical practice. Lung cancer screening N Engl J Med 352 26 2005 2714 2720 [8] S.J. Swensen J.R. Jett T.E. Hartman Lung cancer screening with CT: Mayo Clinic experience Radiology 226 3 2003 756 761 [9] H. MacMahon J.H. Austin G. Gamsu Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society Radiology 237 2 2005 395 400 [10] H.T. Winer-Muram The solitary pulmonary nodule Radiology 239 1 2006 34 49 [11] M.D. Seemann A. Staebler T. Beinert Usefulness of morphological characteristics for the differentiation of benign from malignant solitary pulmonary lesions using HRCT Eur Radiol 9 3 1999 409 417 [12] D.M. Xu H. Gietema H.J. de Koning Nodule management protocol of the NELSON randomised lung cancer screening trial Lung Cancer 54 2 2006 177 184 [13] S. Matsuoka Y. Kurihara K. Yagihashi H. Niimi Y. Nakajima Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema Radiology 235 1 2005 266 273 [14] J.W. Gurney Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory Radiology 186 2 1993 405 413 [15] S. Takashima S. Sone F. Li Y. Maruyama M. Hasegawa M. Kadoya Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions Am J Roentgenol 180 5 2003 1255 1263 [16] S. Takashima S. Sone F. Li Small solitary pulmonary nodules (<or=1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions Am J Roentgenol 180 4 2003 955 964 [17] S. Takashima Y. Maruyama M. Hasegawa CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern Am J Roentgenol 180 3 2003 817 826 [18] Xu DM, Zaag-Loonen vd HJ, Oudkerk M, et al. Cancer risk during one year of follow-up in smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study. Radiology, in press. [19] C.I. Henschke D.F. Yankelevitz D.P. Naidich CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans Radiology 231 1 2004 164 168 [20] S.J. Swensen J.R. Jett J.A. Sloan Screening for lung cancer with low-dose spiral computed tomography Am J Respir Crit Care Med 165 4 2002 508 513 [21] S.J. Swensen J.R. Jett T.E. Hartman CT screening for lung cancer: five-year prospective experience Radiology 235 1 2005 259 265 [22] K. Furuya S. Murayama H. Soeda New classification of small pulmonary nodules by margin characteristics on high-resolution CT Acta Radiol 40 5 1999 496 504 [23] M.D. Seemann O. Seemann W. Luboldt Differentiation of malignant from benign solitary pulmonary lesions using chest radiography, spiral CT and HRCT Lung Cancer 29 2 2000 105 124 [24] C.V. Zwirewich S. Vedal R.R. Miller N.L. Muller Solitary pulmonary nodule: high-resolution CT and radiologic–pathologic correlation Radiology 179 2 1991 469 476 [25] F. Li S. Sone H. Abe H. MacMahon K. Doi Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings Radiology 233 3 2004 793 798 [26] J.C. Wang S. Sone L. Feng Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features Br J Radiol 73 873 2000 930 937 [27] Z. Yang S. Sone S. Takashima F. Li T. Honda T. Yamanda Small peripheral carcinomas of the lung: thin-section CT and pathologic correlation Eur Radiol 9 9 1999 1819 1825 [28] S.S. Siegelman E.A. Zerhouni F.P. Leo N.F. Khouri F.P. Stitik CT of the solitary pulmonary nodule Am J Roentgenol 135 1 1980 1 13 [29] F. Li M. Aoyama J. Shiraishi Radiologists’ performance for differentiating benign from malignant lung nodules on high-resolution CT using computer-estimated likelihood of malignancy Am J Roentgenol 183 5 2004 1209 1215
What problem does this paper attempt to address?
-
P1.11-01 the NELSON Triage Algorithm Applied to a Chinese Biopsied Population: A Pilot Study
H. Beaumont,J. Hu,D. Yang,N. Wang,P. Li,S. Lu,W. Shi,D. Ge,N. Faye,C. Bai
DOI: https://doi.org/10.1016/j.jtho.2018.08.817
IF: 20.121
2018-01-01
Journal of Thoracic Oncology
Abstract:The Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON) lung cancer screening study sequentially tests nodules’ volume, growth and doubling time with an increasing screening interval length. For now, classification performances of NELSON are known only for a European population with specific eligibility criteria. We tested the NELSON trial triage algorithm on a cohort of biopsied Chinese patients. Our study utilized a data subset from the NCT02693496 clinical trial. The data consisted of onsite prospective evaluations of 85 Chinese patients who underwent CTs within an average time interval of 259 days (Min=63; Max=1092). NCT02693496 readers applied the Chinese consensus low-dose CT management guidelines with referral to biopsy, when required. The eligibility criteria were: All genders; age: 18 to 90 years old; chest lesion <3cm. Smoking status was not considered. In our subset of 85 patients, 15 nodules from 15 patients were biopsied: 10 were confirmed malignant; of these, 3 were solid nodules (SN) and 7 were sub-solid nodules (SSN). Five biopsied nodules were confirmed benign. Of the whole cohort, 11.8% (10/85), were declared positive patients. The 75/85 others (88.2%) were declared negative by radiologists and/or pathologists. Using the Lesion Management Solution (LMS) platform (Median Technologies), we retrospectively re-processed the subset of images to analyze NELSON sensitivity at detecting malignant lung nodules. We used R CRAN software for statistics and Chi-Squared test for non-parametric comparison of two sample proportions. We found 12.9% of patients (11/85) displayed no findings. There were 155 detected findings in the remaining 74 patients, which were documented as: 5.2% (8/155) benign as NODCAT I; 9.0% (14/155) pleural; 27.7% (43/155) SSN and 58.1% (90/155) SN. According to NELSON triage, five Patients were declared positive. In the biopsy-confirmed nodules group (10 patients), four were detected by NELSON, one at baseline. All patients displaying SNs were detected (3/3) whereas only one (1/6) patient displaying SSNs was detected. NELSON was better at detecting SNs (p=0.036). One patient with confirmed negative biopsy patient (1/5) was declared positive by NELSON with one SN and one SSN. Additionally, one SN in patient without biopsy was declared positive at baseline by NELSON triage algorithm. Prevalence of different nodule types in this Chinese population was different from the observations of the original European NELSON trial. The NELSON triage algorithm correctly classified patients with malignant SNs but misclassified most patients displaying SSNs. Further studies are needed to better evaluate SSNs by NELSON.
-
Lung Nodule Management in Low-Dose CT Screening for Lung Cancer: Lessons from the NELSON Trial
Danrong Zhong,Grigory Sidorenkov,Colin Jacobs,Pim A de Jong,Hester A Gietema,Ralph Stadhouders,Kristiaan Nackaerts,Joachim G Aerts,Mathias Prokop,Harry J M Groen,Geertruida H de Bock,Rozemarijn Vliegenthart,Marjolein A Heuvelmans
DOI: https://doi.org/10.1148/radiol.240535
IF: 19.7
Radiology
Abstract:Screening with low-dose CT (LDCT) in a high-risk population, as defined by age and smoking behavior, reduces lung cancer-related mortality. However, LDCT screening presents a major challenge. Numerous, mostly benign, nodules are seen in the lungs during screening. The question is how to distinguish the malignant from the benign nodules. Various studies use different protocols for nodule management. The Dutch-Belgian NELSON (Nederlands-Leuvens Longkanker Screenings Onderzoek) trial, the largest European lung cancer screening trial, used distinctions based on nodule volumetric assessment and growth rate. This review discusses key findings from the NELSON study regarding the characteristics of screening-detected nodules, including nodule size and its volumetric assessment, growth rate, subtype, and their associated malignancy risk. These results are compared with findings from other screening studies and current recommendations for lung nodule management. By examining differences in nodule management strategies and providing a comprehensive overview of outcomes specific to lung cancer screening, this review aims to contribute to the broader discussion on optimizing lung nodule management in screening programs.
-
Detection of pulmonary nodules with scoutless fixed-dose ultra-low-dose CT: a prospective study
Gerald Gheysens,Walter De Wever,Lesley Cockmartin,Hilde Bosmans,Walter Coudyzer,Sofie De Vuysere,Mathieu Lefere
DOI: https://doi.org/10.1007/s00330-022-08584-y
Abstract:Objectives: To determine the accuracy of scoutless, fixed-dose ultra-low-dose (ULD) CT compared to standard-dose (SD) CT for pulmonary nodule detection and semi-automated nodule measurement, across different patient sizes. Methods: Sixty-three patients underwent ULD and SD CT. Two readers examined all studies visually and with computer-aided detection (CAD). Nodules detected on SD CT were included in the reference standard by consensus and stratified into 4 categories (nodule category, NODCAT) from the Dutch-Belgian Lung Cancer Screening trial (NELSON). Effects of NODCAT and patient size on nodule detection were determined. For each nodule, volume and diameter were compared between both scans. Results: The reference standard comprised 173 nodules. For both readers, detection rates on ULD versus SD CT were not significantly different for NODCAT 3 and 4 nodules > 50 mm3 (reader 1: 93% versus 89% (p = 0.257); reader 2: 96% versus 98% (p = 0.317)). For NODCAT 1 and 2 nodules < 50 mm3, detection rates on ULD versus SD CT dropped significantly (reader 1: 66% versus 80% (p = 0.023); reader 2: 77% versus 87% (p = 0.039)). Body mass index and chest circumference did not influence nodule detectability (p = 0.229 and p = 0.362, respectively). Calculated volumes and diameters were smaller on ULD CT (p < 0.0001), without altering NODCAT (84% agreement). Conclusions: Scoutless ULD CT reliably detects solid lung nodules with a clinically relevant volume (> 50 mm3) in lung cancer screening, irrespective of patient size. Since detection rates were lower compared to SD CT for nodules < 50 mm3, its use for lung metastasis detection should be considered on a case-by-case basis. Key points: • Detection rates of pulmonary nodules > 50 mm3are not significantly different between scoutless ULD and SD CT (i.e. volumes clinically relevant in lung cancer screening based on the NELSON trial), but were different for the detection of nodules < 50 mm3(i.e. volumes still potentially relevant in lung metastasis screening). • Calculated nodule volumes were on average 0.03 mL or 9% smaller on ULD CT, which is below the 20-25% interscan variability previously reported with software-based volumetry. • Even though a scoutless, fixed-dose ULD CT protocol was used (CTDIvol0.15 mGy), pulmonary nodule detection was not influenced by patient size.
-
Detection and Size Measurements of Pulmonary Nodules in Ultra-Low-dose CT with Iterative Reconstruction Compared to Low Dose CT.
Xin Sui,Felix G. Meinel,Wei Song,Xiaoli Xu,Zixing Wang,Yuyan Wang,Zhengyu Jin,Jiuhong Chen,Rozemarijn Vliegenthart,U. Joseph Schoepf
DOI: https://doi.org/10.1016/j.ejrad.2015.12.013
IF: 4.531
2015-01-01
European Journal of Radiology
Abstract:Background: In this study, the accuracy of ultra-low-dose computed tomography (CT) with iterative reconstruction (IR) for detection and measurement of pulmonary nodules was evaluated.Methods: Eighty-four individuals referred for lung cancer screening (mean age: 54.5 +/- 10.8 years) underwent low-dose computed tomography (LDCT) and ultra-low-dose CT. CT examinations were performed with attenuation-based tube current modulation. Reference tube voltage and current were set to 120 kV/25 mAs for LDCT and 80 kV/4 mAs for ultra-low-dose CT. CT images were reconstructed with filtered back projection (FBP) for LDCT, and with FBP and IR for ultra-low-dose CT datasets. A reference standard was established by a consensus panel of 2 different radiologists on LDCT. Volume and diameter of the solid nodules were measured on LDCT with FBP and ultra-low dose CT with FBP and IR. Interobserver and interscan variability were analyzed and compared by the Bland-Altman method.Results: A total of 127 nodules were identified, including 105 solid nodules, 15 part solid nodules, 7 ground glass nodules. On ultra-low-dose CT scans, the effective radiation dose was 0.13 +/- 0.11 mSv. A total of 113 (88.9%) and 110 (86.6%) true-positive nodules with FBP versus 117 (92.1%) and 118(92.9%) with IR were detected by two observers, respectively. The volume and size of the 105 solid nodules were measured, with mean volume/diameter of 46.5 +/- 46.6 mm(3) /5.1 +/- 1.6 mm. There was no significant difference in nodule volume or diameter measurements between ultra-low-dose CT and LDCT protocols for solid nodules. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
-
Decoding pulmonary nodules: can machine learning enhance malignancy risk stratification?
Colin Jacobs
DOI: https://doi.org/10.1136/thorax-2023-221300
2024-03-16
Thorax
Abstract:Randomised controlled trials, with the National Lung Screening Trial and Dutch-Belgian NELSON trial being the two largest, have demonstrated that lung cancer screening of high-risk individuals using low-dose CT reduces lung cancer mortality compared with no screening or screening with chest X-ray. Fuelled by the positive results of these landmark trials, low-dose CT-based lung cancer screening of high-risk individuals is being implemented at national or regional scale in an increasing number of countries worldwide. A comprehensive overview of the current status of implementation of lung cancer screening worldwide can be observed in the interactive lung cancer screening overview maintained by the Lung Cancer Policy Network.1 One of the challenges in the radiological interpretation of screening CT scans is the management of screen-detected pulmonary nodules. The prevalence of nodules in screening CT scans of the eligible population is high and ranges from 22% to 74%, depending on the...
respiratory system
-
[The volume and mass growth of persisted pulmonary nodules detected in low-dose CT screening and its influence factors].
Y. Jin,N. Wu,Q. Sun,L. Zhang,W. Tang,Y. Huang,S. Zhao
DOI: https://doi.org/10.3760/cma.j.issn.0253-3766.2018.04.007
2018-04-23
Abstract:Objective: To evaluate the changes of volume and mass of pulmonary nodules which were detected in low-dose computed tomography (LDCT) screening, and to analyze the influencing factors. Methods: This retrospective study analyzed the CT images of the participants who underwent at least two chest LDCT scanning from March 2009 to December 2015 in National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. The inclusion criteria was the nodule diameter ≥6 mm; the volume growth was defined as ≥20%. Fifty-one pulmonary nodules (PNs) were selected among 51 enrolled participants (26 men and 25 women). According to characteristic of nodule and risk stratification of participant, the nodules were classified into different groups (10 non-solid nodules, 17 part-solid nodules and 24 solid nodules; 14 PNs in high-risk group, 12 PNs in moderate-risk group and 25 PNs in low-risk group). The Lung-VCAR software was used to measure the diameter and volume of the PNs, and all nodules were calculated for the volume doubling time (VDT) and mass doubling time (MDT). Results: Among the 51 PNs, the diameter of 33 nodules increased more than 1.5 mm while 18 nodules increased less than 1.5 mm. The median VDT of part-solid nodules was 364 days, which was shorter than that of non-solid nodules and solid nodules (761 and 819 days, respectively), the differences were statistically significant (both P<0.05). The median MDT of part-solid nodules was 351 days, which was lower than that of non-solid nodules and solid nodules (772 days and 840 days, respectively). The difference was statistically significant (P<0.05). The median VDT and MDT of the pulmonary nodules in the high-risk group were 181 days and 256 days, respectively, which were lower than those in the low risk group (1 037 days and 1 035 days, respectively). VDT has good correlation with MDT (r=0.909, P<0.001). Conclusions: Both the characteristic of PNs and the risk status of the participants could affect the growth of nodules in LDCT screening. The part-solid nodules and high-risk group nodules grew relatively faster, which should be closely focused on. Compared with the two-dimensional diameter, the three-dimensional quantitative indicators (VDT and MDT) were more sensitive for nodule growth. The mass changes of part-solid nodules were earlier than that of volume.
Medicine
-
Characteristics of lung nodules detected by low-dose CT scan: results from the French lung cancer screening study DEP KP80
Storme,N.,Auquier,M.,Petigny,V.,Couraud,S.,Jounieaux,V.,Leleu,O.
DOI: https://doi.org/10.1183/13993003.congress-2024.oa4678
IF: 24.3
2024-11-01
European Respiratory Journal
Abstract:Introduction: DEP KP80 was a real-life prospective study assessing the efficacy of lung cancer screening using low-dose CT scan (LDCT) Objectives: To compare the scanographic characteristics and profiles of participants with benign and malignant nodules detected during a lung cancer screening program. Patients and Methods: The DEP KP80 study included participants aged 55 to 74 years, active smokers or having quit smoking for less than 15 years, with a smoking habit of at least 30 pack-years. A total of 1,711 annual LDCT screenings were performed during the three rounds. Results: Overall, 1,050 nodules were detected in 408 of the 1,029 participants screened (39.6%). Mean age was 61.9±5.3 years and 65.9% were men. Moreover, 86.4% of nodules were solid, 9.1% were ground-glass, and 4.5% were mixed. Regarding their location, 45% of nodules were in the upper lobes, 12.9% in the middle lobe, and 42.1% in the lower lobes. They measured less than 4mm in 42.5%, between 5 and 10 mm in 46.9%, and over 10mm in 10.6% of cases. Nodules were malignant in 43 of the 408 participants (10.5%). In multivariate analysis, multiple nodules were predictive of benignity, a diameter >10mm was predictive of cancer, and a location in the upper lobes was a risk factor at the limit of significance (p=0.06). No significant differences were found regarding age, sex, or nodule density. Conclusion: This analysis of a real-life lung cancer screening study highlighted that isolated supra-centimetric lung nodules located in the upper lobes and detected by LDCT should be considered malignant until proven otherwise.
respiratory system
-
Determination of the optimum definition of growth evaluation for indeterminate pulmonary nodules detected in lung cancer screening
Jong Hyuk Lee,Eui Jin Hwang,Woo Hyeon Lim,Jin Mo Goo
DOI: https://doi.org/10.1371/journal.pone.0274583
IF: 3.7
2022-09-16
PLoS ONE
Abstract:To determine the optimum definition of growth for indeterminate pulmonary nodules detected in lung cancer screening. Individuals with indeterminate nodules as defined by volume of 50–500 mm 3 (solid nodules) and solid component volume of 50–500 mm 3 or average diameter of non-solid component ≥8 mm (part-solid nodules) on baseline lung cancer screening low-dose chest CT (LDCT) were included. The average diameters and volumes of the nodules were measured on baseline and follow-up LDCTs with semi-automated segmentation. Sensitivities and specificities for lung cancer diagnosis of nodule growth defined by a) percentage volume growth ≥25% (defined in the NELSON study); b) absolute diameter growth >1.5 mm (defined in the Lung-RADS version 1.1); and c) subjective decision by a radiologist were evaluated. Sensitivities and specificities of diagnostic referral based on various thresholds of volume doubling time (VDT) were also evaluated. Altogether, 115 nodules (one nodule per individual; 93 solid and 22 part-solid nodules; 105 men; median age, 68 years) were evaluated (median follow-up interval: 201 days; interquartile range: 127–371 days). Percentage volume growth ≥25% exhibited higher sensitivity but lower specificity than those of diametrical measurement compared to absolute diameter growth >1.5 mm (sensitivity, 69.2% vs. 42.3%, p = 0.023; specificity, 82.0% vs. 96.6%, p = 0 . 002 ). The radiologist had an equivalent sensitivity (53.9%; p = 0.289) but higher specificity (98.9%; p = 0.002) compared to those of volume growth, but did not differ from those of diameter growth ( p >0.05 both in sensitivity and specificity). Compared to the VDT threshold of 600 days (sensitivity, 61.5%; specificity, 87.6%), VDT thresholds ≤200 and ≤300 days exhibited significantly lower sensitivity (30.8%, p = 0.013) and higher specificity (94.4%, p = 0.041), respectively. Growth evaluation of screening-detected indeterminate nodules with volumetric measurement exhibited higher sensitivity but lower specificity compared to diametric measurements.
multidisciplinary sciences
-
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trial
Sidorenkov, Grigory,Vliegenthart, Rozemarijn
DOI: https://doi.org/10.1007/s10654-023-00975-9
2023-03-22
European Journal of Epidemiology
Abstract:Trials show that low-dose computed tomography (CT) lung cancer screening in long-term (ex-)smokers reduces lung cancer mortality. However, many individuals were exposed to unnecessary diagnostic procedures. This project aims to improve the efficiency of lung cancer screening by identifying high-risk participants, and improving risk discrimination for nodules. This study is an extension of the Dutch-Belgian Randomized Lung Cancer Screening Trial, with a focus on personalized outcome prediction (NELSON-POP). New data will be added on genetics, air pollution, malignancy risk for lung nodules, and CT biomarkers beyond lung nodules (emphysema, coronary calcification, bone density, vertebral height and body composition). The roles of polygenic risk scores and air pollution in screen-detected lung cancer diagnosis and survival will be established. The association between the AI-based nodule malignancy score and lung cancer will be evaluated at baseline and incident screening rounds. The association of chest CT imaging biomarkers with outcomes will be established. Based on these results, multisource prediction models for pre-screening and post-baseline-screening participant selection and nodule management will be developed. The new models will be externally validated. We hypothesize that we can identify 15–20% participants with low-risk of lung cancer or short life expectancy and thus prevent ~140,000 Dutch individuals from being screened unnecessarily. We hypothesize that our models will improve the specificity of nodule management by 10% without loss of sensitivity as compared to assessment of nodule size/growth alone, and reduce unnecessary work-up by 40–50%.
public, environmental & occupational health
-
Radiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients
Xing Hu,Jiangmin Zhao,Haishan Qian,Guangyan Du,Margaret Kelly,Hua Yang
DOI: https://doi.org/10.1016/j.ejro.2016.08.001
2016-08-16
Abstract:Purpose: Once lung cancer is detected due to clinical symptoms or by being visible on chest X-ray, it is usually high stage and non-operable. In order to improve mortality rates in lung cancer, low-dose CT (LDCT) screening of "high risk" individuals is gaining popularity. However, the rate of malignancy in LDCT detected sub-centimetre lung nodules is not clear. We aimed to analyze surgically resected specimens in this patient group to explore cost effectiveness and recommendations for clinical management of these nodules. Material & methods: Our hospital pathology database was searched for sub-centimeter lung nodules detected by LDCT screening which were resected. The patient demographics were collected and the radiologic and pathologic characteristics of those nodules were analyzed. Results: From the records, 44 patients with 46 resected subcentimetre nodules were identified. Patients were selected for surgery based on an irregular shape, growth in size during follow up, family history of lung cancer or personal history of cancer of other sites, previous lung disease, smoking and personal anxiety. Of the 44 patients, 33 were women and the ages ranged from 43 to 76 years (56.75 ± 8.44). All nodules were equal to, or less than 10 mm with a mean diameter of 7.81 ± 1.80 mm (SD). Out of 46 nodules, the pathological diagnoses were: invasive adenocarcinoma (ACa) in 4 (8.7%); adenocarcinoma in situ (AIS) or atypical adenomatous hyperplasia (AAH) in 29 (63%); benign fibrosis/fibrotic scar with inflammation or calcification in 12 (26.1%); an intrapulmonary benign lymph node in 1 (2.2%). Of the ACa, AIS and AAH groups (a total of 31 patients), 77% were women (24 vs. 7). The cancer or pre-cancer nodules (ACa, AIS and AAH) tended to be larger than benign fibrotic scars (P = 0.039). Amongst all characteristics, significant statistical differences were found when the following radiological features were considered: reconstructed nodule shape (P = 0.011), margin (P = 0.003) and ground glass pattern (P = 0.000). The patient's age, the axial morphology of the lesion, relationship to major vessels or visceral pleura and location within the lung parenchyma were not predictive of the pathologic diagnosis. Only one of the 31 patients with a cancer or pre-cancer nodule was a smoker. Conclusion: ACa, AIS and AAH nodules detected on LDCT included more women (77%) than men in our cohort. Smoking as inclusive criteria for LDCT screening of lung cancer needs to be further evaluated in the Chinese population. The reconstructed nodule shape, density and margin may help radiologists to identify small cancer and pre-cancer nodules from benign conditions.
-
Detection of solid and subsolid pulmonary nodules with lung MRI: performance of UTE, T1 gradient-echo, and single-shot T2 fast spin echo
Felipe Sanchez,Pascal N Tyrrell,Patrick Cheung,Chinthaka Heyn,Simon Graham,Ian Poon,Yee Ung,Alexander Louie,May Tsao,Anastasia Oikonomou
DOI: https://doi.org/10.1186/s40644-023-00531-4
IF: 5.605
2023-02-16
Cancer Imaging
Abstract:Background: Although MRI is a radiation-free imaging modality, it has historically been limited in lung imaging due to inherent technical restrictions. The aim of this study is to explore the performance of lung MRI in detecting solid and subsolid pulmonary nodules using T1 gradient-echo (GRE) (VIBE, Volumetric interpolated breath-hold examination), ultrashort time echo (UTE) and T2 Fast Spin Echo (HASTE, Half fourier Single-shot Turbo spin-Echo). Methods: Patients underwent a lung MRI in a 3 T scanner as part of a prospective research project. A baseline Chest CT was obtained as part of their standard of care. Nodules were identified and measured on the baseline CT and categorized according to their density (solid and subsolid) and size (> 4 mm/ ≤ 4 mm). Nodules seen on the baseline CT were classified as present or absent on the different MRI sequences by two thoracic radiologists independently. Interobserver agreement was determined using the simple Kappa coefficient. Paired differences were compared using nonparametric Mann-Whitney U tests. The McNemar test was used to evaluate paired differences in nodule detection between MRI sequences. Results: Thirty-six patients were prospectively enrolled. One hundred forty-nine nodules (100 solid/49 subsolid) with mean size 10.8 mm (SD = 9.4) were included in the analysis. There was substantial interobserver agreement (k = 0.7, p = 0.05). Detection for all nodules, solid and subsolid nodules was respectively; UTE: 71.8%/71.0%/73.5%; VIBE: 61.6%/65%/55.1%; HASTE 72.4%/72.2%/72.7%. Detection rate was higher for nodules > 4 mm in all groups: UTE 90.2%/93.4%/85.4%, VIBE 78.4%/88.5%/63.4%, HASTE 89.4%/93.8%/83.8%. Detection of lesions ≤4 mm was low for all sequences. UTE and HASTE performed significantly better than VIBE for detection of all nodules and subsolid nodules (diff = 18.4 and 17.6%, p = < 0.01 and p = 0.03, respectively). There was no significant difference between UTE and HASTE. There were no significant differences amongst MRI sequences for solid nodules. Conclusions: Lung MRI shows adequate performance for the detection of solid and subsolid pulmonary nodules larger than 4 mm and can serve as a promising radiation-free alternative to CT.
-
Impact on Image Quality and Diagnostic Performance of Dual-Layer Detector Spectral CT for Pulmonary Subsolid Nodules: Comparison With Hybrid and Model-Based Iterative Reconstruction
Li Ding,Xiaomei Li,Jie Lin,Shuting Deng,Mingwang Chen,Weiwei Deng,Yikai Xu,Zhao Chen,Chenggong Yan
DOI: https://doi.org/10.1097/RCT.0000000000001640
2024-07-30
Abstract:Objective: To evaluate the image quality and diagnostic performance of pulmonary subsolid nodules on conventional iterative algorithms, virtual monoenergetic images (VMIs), and electron density mapping (EDM) using a dual-layer detector spectral CT (DLSCT). Methods: This retrospective study recruited 270 patients who underwent DLSCT scan for lung nodule screening or follow-up. All CT examinations with subsolid nodules (pure ground-glass nodules [GGNs] or part-solid nodules) were reconstructed with hybrid and model-based iterative reconstruction, VMI at 40, 70, 100, and 130 keV levels, and EDM. The CT number, objective image noise, signal-to-noise ratio, contrast-to-noise ratio, diameter, and volume of subsolid nodules were measured for quantitative analysis. The overall image quality, image noise, visualization of nodules, artifact, and sharpness were subjectively rated by 2 thoracic radiologists on a 5-point scale (1 = unacceptable, 5 = excellent) in consensus. The objective image quality measurements, diameter, and volume were compared among the 7 groups with a repeated 1-way analysis of variance. The subjective scores were compared with Kruskal-Wallis test. Results: A total of 198 subsolid nodules, including 179 pure GGNs, and 19 part-solid nodules were identified. Based on the objective analysis, EDM had the highest signal-to-noise ratio (164.71 ± 133.60; P < 0.001) and contrast-to-noise ratio (227.97 ± 161.96; P < 0.001) among all image sets. Furthermore, EDM had a superior mean subjective rating score (4.80 ± 0.42) for visualization of GGNs compared to other reconstructed images (all P < 0.001), although the model-based iterative reconstruction had superior subjective scores of overall image quality. For pure GGNs, the measured diameter and volume did not significantly differ among different reconstructions (both P > 0.05). Conclusions: EDM derived from DLSCT enabled improved image quality and lesion conspicuity for the evaluation of lung subsolid nodules compared to conventional iterative reconstruction algorithms and VMIs.
-
Analysis of Pulmonary Nodules Detected by Annual Low-Dose Computed Tomography in the Elderly During a 10-Year Follow-Up.
Zhonghui Liu,Xinmin Liu,Lianfang Ni
DOI: https://doi.org/10.1111/ggi.14479
2022-01-01
Abstract:Aim To describe pulmonary nodules detected by annual low-dose computed tomography (LDCT) in the elderly during a 10-year follow-up, and to provide a basis for clinical decision-making in the elderly. Methods In this retrospective study, patients who completed at least a 3-year follow-up visit with annual LDCT imaging data were eligible for inclusion. The evolution of pulmonary nodules was evaluated, including malignant, suspicious malignant, benign and undetermined nodules. Additionally, the nature and outcome of new nodules during the follow-up were analyzed. Results For the 365 subjects included, 899 positive pulmonary nodules were detected in 286 patients. Among these there were 788 solid nodules, 20 part-solid nodules and 91 nonsolid nodules. The detection rate of positive nodules and of lung cancer was 78.4% and 5.5%, respectively. 99.7% (786/788) of solid nodules were benign, and 75% (15/20) of part-solid nodules and 28.6% (26/91) of nonsolid nodules were malignant or suspected malignant. 124 new positive nodules appeared during the annual follow-up, but 58.9% of them subsequently disappeared. Significant higher detection rates of 10-20-mm nodules (P = 0.0485) and suspicious malignant nodules (P = 0.017) were observed in subjects over 75 years old as compared with those under 75 years old. Conclusions Solid nodules accounted for the highest proportion of lung nodules screened at baseline, and most of them were benign. The malignant probability of part-solid nodules was the highest. Most newly appeared nodules disappeared during subsequent follow-up. The proportions of suspicious malignant nodules and 10-20-mm nodules in subjects over 75 years old were higher than in those under 75 years old. Geriatr Gerontol Int 2022; center dot center dot: center dot center dot-center dot center dot.
-
Prevalence of pulmonary nodules detected incidentally on noncancer‐related imaging: a review
Ankush Das,Asha Bonney,Renee Manser
DOI: https://doi.org/10.1111/imj.16502
2024-09-01
Internal Medicine Journal
Abstract:Pulmonary nodules are common incidental findings requiring surveillance. Follow‐up recommendations vary depending on risk factors, size and solid or subsolid characteristics. This review aimed to evaluate the prevalence of clinically significant nodules detected on noncancer‐dedicated imaging and the prevalence of part‐solid and ground‐glass nodules. We conducted a systematic search of literature and screened texts for eligibility. Clinically significant nodules were noncalcified nodules >4–6 mm. Prevalence estimates were calculated for all studies and risk of bias was assessed by one reviewer. Twenty‐four studies were included, with a total of 30 887 participants, and 21 studies were cross‐sectional in design. Twenty‐two studies used computed tomography (CT) imaging with cardiac‐related CT being the most frequent. Prevalence of significant nodules was highest in studies with large field of view of the chest and low size thresholds for reporting nodules. The prevalence of part‐solid and ground‐glass nodules was only described in two cardiac‐related CT studies. The overall risk of bias was low in seven studies and moderate in 17 studies. While current literature frequently reports incidental nodules on cardiovascular‐related CT, there is minimal reporting of subsolid characteristics. Unclear quantification of smoking history and heterogeneity of imaging protocol also limits reliable evaluation of nodule prevalence in nonscreening cohorts.
medicine, general & internal
-
Shape-Sensing Robotic-Assisted Bronchoscopy versus Computed Tomography-Guided Transthoracic Biopsy for the Evaluation of Subsolid Pulmonary Nodules
Sebastian Fernandez-Bussy,Alejandra Yu Lee-Mateus,Janani Reisenauer,Prasanth Balasubramanian,Alanna Barrios-Ruiz,Ana Garza-Salas,Nikitha C Chandra,Anoop Koratala,Anthony Nadrous,Eric S Edell,Andrew W Bowman,Rolf A Grage,Chris J Reisenauer,Anil N Kurup,Neal M Patel,Ryan Chadha,Britney N Hazelett,David Abia-Trujillo,Nikitha C. Chandra,Eric S. Edell,Andrew W. Bowman,Rolf A. Grage,Chris J. Reisenauer,Anil N. Kurup,Neal M. Patel,Britney N. Hazelett
DOI: https://doi.org/10.1159/000538132
2024-03-12
Respiration
Abstract:Introduction: Lung cancer remains the leading cause of cancer death worldwide. Subsolid nodules (SSN), including ground glass nodules (GGN) and part solid nodules (PSN), are slow growing but have a higher risk for malignancy. Therefore, timely diagnosis is imperative. Shape-sensing robotic-assisted bronchoscopy (ssRAB) has emerged as reliable diagnostic procedure, but data on SSN and how ssRAB compares to other diagnostic interventions such as CT-guided transthoracic biopsy (CTTB) is scarce. In this study, we compared diagnostic yield of ssRAB versus CTTB for evaluating SSN. Methods: A retrospective study of consecutive patients who underwent either ssRAB or CTTB for evaluating GGN and PSN with a solid component less than 6mm, from February 2020 to April 2023 at Mayo Clinic Florida and Rochester. Clinicodemographic information, nodule characteristics, diagnostic yield, and complications were compared between ssRAB and CTTB. Results: A total of 66 nodules from 65 patients were evaluated: 37 PSN and 29 GGN. Median size of PSN solid component was 5mm (IQR 4.5, 6). Patients were divided in two groups: 27 in the ssRAB group and 38 in the CCTB group. Diagnostic yield was 85.7% for ssRAB and 89.5% for CTTB (p= .646). Sensitivity for malignancy was similar between ssRAB and CTTB (86.4% vs 88.5%; p= .828), with no statistical difference. Complications were more frequent in CTTB with no significant difference (8 vs 2; p= .135). Conclusion: Diagnostic yield for SSN was similarly high for ssRAB and CTTB, with ssRAB presenting less complications and allowing mediastinal staging within the same procedure.
respiratory system
-
Benign‐malignant classification of pulmonary nodules by low‐dose spiral computerized tomography and clinical data with machine learning in opportunistic screening
Yansong Zheng,Jing Dong,Xue Yang,Ping Shuai,Yongli Li,Hailin Li,Shengyong Dong,Yan Gong,Miao Liu,Qiang Zeng
DOI: https://doi.org/10.1002/cam4.5886
IF: 4.711
2023-05-30
Cancer Medicine
Abstract:Background Many people were found with pulmonary nodules during physical examinations. It is of great practical significance to discriminate benign and malignant nodules by using data mining technology. Methods The subjects' demographic data, baseline examination results, and annual follow‐up low‐dose spiral computerized tomography (LDCT) results were recorded. The findings from annual physical examinations of positive nodules, including highly suspicious nodules and clinically tentative benign nodules, was analyzed. The extreme gradient boosting (XGBoost) model was constructed and the Grid Search CV method was used to select the super parameters. External unit data were used as an external validation set to evaluate the generalization performance of the model. Results A total of 135,503 physical examinees were enrolled. Baseline testing found that 27,636 (20.40%) participants had clinically tentative benign nodules and 611 (0.45%) participants had highly suspicious nodules. The proportion of highly suspicious nodules in participants with negative baseline was about 0.12%–0.46%, which was lower than the baseline level except the follow‐up of >5 years. In the 27,636 participants with clinically tentative benign nodules, only in the first year of LDCT re‐examination was the proportion of highly suspicious nodules (1.40%) significantly greater than that of baseline screening (0.45%) (p 0.05). Furthermore, 322 cases with benign nodules and 196 patients with malignant nodules confirmed by surgery and pathology were compared. A model and the top 15 most important clinical variables were determined by XGBoost algorithm. The area under the curve (AUC) of the model was 0.76 [95% CI: 0.67–0.84], and the accuracy was 0.75. The sensitivity and specificity of the model under this threshold were 0.78 and 0.73, respectively. In the validation of model using external data, the AUC was 0.87 and the accuracy was 0.80. The sensitivity and specificity were 0.83 and 0.77, respectively. Conclusions It is important that pulmonary nodules could be more accurately identified at the first LDCT examination. A model with 15 variables which are routinely measured in the clinic could be helpful to distinguish benign and malignant nodules. It could help the radiological team issue a more accurate report; and it may guide the clinical team regarding LDCT follow‐up.
oncology
-
Ultra-low-dose CT Reconstructed with ASiR-V Using SmartmA for Pulmonary Nodule Detection and Lung-RADS Classifications Compared with Low-Dose CT
K. Ye,M. Chen,J. Li,Q. Zhu,Y. Lu,H. Yuan
DOI: https://doi.org/10.1016/j.crad.2020.10.014
IF: 3.389
2021-01-01
Clinical Radiology
Abstract:AIM: To evaluate the accuracy of ultra-low-dose computed tomography (ULDCT) with ASiR-V using a noise index (SmartmA) for pulmonary nodule detection and Lung CT Screening Reporting And Data System (Lung-RADS) classifications compared with low-dose CT (LDCT). MATERIALS AND METHODS: Two-hundred and ten patients referred for lung cancer screening underwent conventional chest LDCT (0.80 +/- 0.28 mSv) followed immediately by ULDCT (0.16 +/- 0.03 mSv). ULDCT was scanned using 120 kV/SmartmA with a noise index of 28 HU and reconstructed with ASiR-V70%. The types and diameters of all nodules were recorded. The attenuation of pure ground-glass nodules (pGGNs) was measured on LDCT. All nodules were further classified using Lung-RADS. Sensitivities of nodule detection on ULDCT were analysed using LDCT as the reference standard. Logistic regression was used to establish a prediction model for the sensitivity of nodules. RESULTS: LDCT revealed 362 nodules and the overall sensitivity on ULDCT was 90.1%. The sensitivity for solid nodules (SNs) of >= 1 mm diameter was 96.6% (228/236) and 100% (26/26) for SNs of 6 mm diameter. For pGGNs of >= 6 mm, the overall sensitivity was 93% (40/43) and 100% (29/29) for nodules with a attenuation value 700 HU or more. The agreement of Lung-RADS classification between two scans was good. On logistic regression, diameter was the only independent predictor for sensitivity of SNs (p<0.05). Diameter and attenuation value were predictors for pGGNs (p<0.05). CONCLUSION: ULDCT with ASiR-V using SmartmA is suitable for lung-cancer screening in people with a BMI <= 35 kg/m(2) as it has a low radiation dose of 0.16 mSv, high sensitivity for nodule detection and good performance of Lung-RADS classifications. (C) 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
-
Automated detection of lung nodules in CT scans: Preliminary results
Samuel G. Armato,Maryellen L. Giger,Heber MacMahon
DOI: https://doi.org/10.1118/1.1387272
IF: 4.506
2001-08-01
Medical Physics
Abstract:We have developed a fully automated computerized method for the detection of lung nodules in helical computed tomography (CT) scans of the thorax. This method is based on two-dimensional and three-dimensional analyses of the image data acquired during diagnostic CT scans. Lung segmentation proceeds on a section-by-section basis to construct a segmented lung volume within which further analysis is performed. Multiple gray-level thresholds are applied to the segmented lung volume to create a series of thresholded lung volumes. An 18-point connectivity scheme is used to identify contiguous three-dimensional structures within each thresholded lung volume, and those structures that satisfy a volume criterion are selected as initial lung nodule candidates. Morphological and gray-level features are computed for each nodule candidate. After a rule-based approach is applied to greatly reduce the number of nodule candidates that corresponds to nonnodules, the features of remaining candidates are merged through linear discriminant analysis. The automated method was applied to a database of 43 diagnostic thoracic CT scans. Receiver operating characteristic (ROC) analysis was used to evaluate the ability of the classifier to differentiate nodule candidates that correspond to actual nodules from false-positive candidates. The area under the ROC curve for this categorization task attained a value of 0.90 during leave-one-out-by-case evaluation. The automated method yielded an overall nodule detection sensitivity of 70% with an average of 1.5 false-positive detections per section when applied to the complete 43-case database. A corresponding nodule detection sensitivity of 89% with an average of 1.3 false-positive detections per section was achieved with a subset of 20 cases that contained only one or two nodules per case.
radiology, nuclear medicine & medical imaging
-
Effect of maximal medical therapy on refractoriness of unstable angina pectoris.
D. Grambow,E. Topol
DOI: https://doi.org/10.1016/0002-9149(92)90194-4
1992-09-01
Abstract:
-
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
Fiona J Gilbert,Scott Harris,Kenneth A Miles,Jonathan R Weir-McCall,Nagmi R Qureshi,Robert C Rintoul,Sabina Dizdarevic,Lucy Pike,Donald Sinclair,Andrew Shah,Rosemary Eaton,Andrew Clegg,Valerio Benedetto,James E Hill,Andrew Cook,Dimitrios Tzelis,Luke Vale,Lucy Brindle,Jackie Madden,Kelly Cozens,Louisa A Little,Kathrin Eichhorst,Patricia Moate,Chris McClement,Charles Peebles,Anindo Banerjee,Sai Han,Fat Wui Poon,Ashley M Groves,Lutfi Kurban,Anthony J Frew,Matthew E Callister,Philip Crosbie,Fergus V Gleeson,Kavitasagary Karunasaagarar,Osei Kankam,Steve George
DOI: https://doi.org/10.3310/WCEI8321
Abstract:Background: Current pathways recommend positron emission tomography-computerised tomography for the characterisation of solitary pulmonary nodules. Dynamic contrast-enhanced computerised tomography may be a more cost-effective approach. Objectives: To determine the diagnostic performances of dynamic contrast-enhanced computerised tomography and positron emission tomography-computerised tomography in the NHS for solitary pulmonary nodules. Systematic reviews and a health economic evaluation contributed to the decision-analytic modelling to assess the likely costs and health outcomes resulting from incorporation of dynamic contrast-enhanced computerised tomography into management strategies. Design: Multicentre comparative accuracy trial. Setting: Secondary or tertiary outpatient settings at 16 hospitals in the UK. Participants: Participants with solitary pulmonary nodules of ≥ 8 mm and of ≤ 30 mm in size with no malignancy in the previous 2 years were included. Interventions: Baseline positron emission tomography-computerised tomography and dynamic contrast-enhanced computer tomography with 2 years' follow-up. Main outcome measures: Primary outcome measures were sensitivity, specificity and diagnostic accuracy for positron emission tomography-computerised tomography and dynamic contrast-enhanced computerised tomography. Incremental cost-effectiveness ratios compared management strategies that used dynamic contrast-enhanced computerised tomography with management strategies that did not use dynamic contrast-enhanced computerised tomography. Results: A total of 380 patients were recruited (median age 69 years). Of 312 patients with matched dynamic contrast-enhanced computer tomography and positron emission tomography-computerised tomography examinations, 191 (61%) were cancer patients. The sensitivity, specificity and diagnostic accuracy for positron emission tomography-computerised tomography and dynamic contrast-enhanced computer tomography were 72.8% (95% confidence interval 66.1% to 78.6%), 81.8% (95% confidence interval 74.0% to 87.7%), 76.3% (95% confidence interval 71.3% to 80.7%) and 95.3% (95% confidence interval 91.3% to 97.5%), 29.8% (95% confidence interval 22.3% to 38.4%) and 69.9% (95% confidence interval 64.6% to 74.7%), respectively. Exploratory modelling showed that maximum standardised uptake values had the best diagnostic accuracy, with an area under the curve of 0.87, which increased to 0.90 if combined with dynamic contrast-enhanced computerised tomography peak enhancement. The economic analysis showed that, over 24 months, dynamic contrast-enhanced computerised tomography was less costly (£3305, 95% confidence interval £2952 to £3746) than positron emission tomography-computerised tomography (£4013, 95% confidence interval £3673 to £4498) or a strategy combining the two tests (£4058, 95% confidence interval £3702 to £4547). Positron emission tomography-computerised tomography led to more patients with malignant nodules being correctly managed, 0.44 on average (95% confidence interval 0.39 to 0.49), compared with 0.40 (95% confidence interval 0.35 to 0.45); using both tests further increased this (0.47, 95% confidence interval 0.42 to 0.51). Limitations: The high prevalence of malignancy in nodules observed in this trial, compared with that observed in nodules identified within screening programmes, limits the generalisation of the current results to nodules identified by screening. Conclusions: Findings from this research indicate that positron emission tomography-computerised tomography is more accurate than dynamic contrast-enhanced computerised tomography for the characterisation of solitary pulmonary nodules. A combination of maximum standardised uptake value and peak enhancement had the highest accuracy with a small increase in costs. Findings from this research also indicate that a combined positron emission tomography-dynamic contrast-enhanced computerised tomography approach with a slightly higher willingness to pay to avoid missing small cancers or to avoid a 'watch and wait' policy may be an approach to consider. Future work: Integration of the dynamic contrast-enhanced component into the positron emission tomography-computerised tomography examination and the feasibility of dynamic contrast-enhanced computerised tomography at lung screening for the characterisation of solitary pulmonary nodules should be explored, together with a lower radiation dose protocol. Study registration: This study is registered as PROSPERO CRD42018112215 and CRD42019124299, and the trial is registered as ISRCTN30784948 and ClinicalTrials.gov NCT02013063. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 26, No. 17. See the NIHR Journals Library website for further project information.